Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Inuzuka

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Nature Reviews. Cancer|March 25, 2014
Roles of F-box proteins in cancerZhiwei Wang, Pengda Liu, Hiroyuki Inuzuka, et al.
Cell Division|June 25, 2009
Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1Daming Gao, Hiroyuki Inuzuka, Alan Tseng, et al.
The Journal of Biological Chemistry|March 4, 2023
Targeted protein posttranslational modifications by chemically induced proximity for cancer therapyYunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Cell Research|May 7, 2025
Lysosomal EGFR functions as a GEF for RhebTao Hou, Peiqiang Yan, Hiroyuki Inuzuka, et al.
Oncotarget|February 15, 2011
Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destructionHiroyuki Inuzuka, Hidefumi Fukushima, Shavali Shaik, et al.
Discovery Medicine|February 5, 2013
Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasisJiateng Zhong, Kohei Ogura, Zhiwei Wang, et al.
Seminars in Cancer Biology|July 7, 2022
Targeting micro-environmental pathways by PROTACs as a therapeutic strategyJing Liu, Yunhua Peng, Hiroyuki Inuzuka, et al.
Acta Materia Medica|August 20, 2025
PROTAC technology for prostate cancer treatmentZhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.
Fundamental Research|January 30, 2026
Protein neddylation in lung tumorigenesis: Target validation and targeted therapyYawen Zheng, Hiroyuki Inuzuka, Wenyi Wei, et al.
Acta Materia Medica|March 3, 2022
PROTACs technology for treatment of Alzheimer's disease: Advances and perspectivesHiroyuki Inuzuka, Jing Liu, Wenyi Wei, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Nature Reviews. Cancer|March 25, 2014
Roles of F-box proteins in cancerZhiwei Wang, Pengda Liu, Hiroyuki Inuzuka, et al.
Cell Division|June 25, 2009
Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1Daming Gao, Hiroyuki Inuzuka, Alan Tseng, et al.
The Journal of Biological Chemistry|March 4, 2023
Targeted protein posttranslational modifications by chemically induced proximity for cancer therapyYunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Cell Research|May 7, 2025
Lysosomal EGFR functions as a GEF for RhebTao Hou, Peiqiang Yan, Hiroyuki Inuzuka, et al.
Oncotarget|February 15, 2011
Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destructionHiroyuki Inuzuka, Hidefumi Fukushima, Shavali Shaik, et al.
Discovery Medicine|February 5, 2013
Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasisJiateng Zhong, Kohei Ogura, Zhiwei Wang, et al.
Seminars in Cancer Biology|July 7, 2022
Targeting micro-environmental pathways by PROTACs as a therapeutic strategyJing Liu, Yunhua Peng, Hiroyuki Inuzuka, et al.
Acta Materia Medica|August 20, 2025
PROTAC technology for prostate cancer treatmentZhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.
Fundamental Research|January 30, 2026
Protein neddylation in lung tumorigenesis: Target validation and targeted therapyYawen Zheng, Hiroyuki Inuzuka, Wenyi Wei, et al.
Acta Materia Medica|March 3, 2022
PROTACs technology for treatment of Alzheimer's disease: Advances and perspectivesHiroyuki Inuzuka, Jing Liu, Wenyi Wei, et al.
Pageof 15